000 01582 a2200457 4500
005 20250513144638.0
264 0 _c19980707
008 199807s 0 0 eng d
022 _a0019-2805
024 7 _a10.1046/j.1365-2567.1998.00438.x
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aHaig, D M
245 0 0 _aThe orf virus OV20.0L gene product is involved in interferon resistance and inhibits an interferon-inducible, double-stranded RNA-dependent kinase.
_h[electronic resource]
260 _bImmunology
_cMar 1998
300 _a335-40 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAnimals
650 0 4 _aCells, Cultured
650 0 4 _aDrug Resistance, Microbial
650 0 4 _aEnzyme Activation
_xdrug effects
650 0 4 _aEnzyme Inhibitors
_xpharmacology
650 0 4 _aHeLa Cells
650 0 4 _aHumans
650 0 4 _aInterferon Type I
_xpharmacology
650 0 4 _aInterferon-gamma
_xpharmacology
650 0 4 _aInterferons
_xpharmacology
650 0 4 _aMuscle, Skeletal
_xdrug effects
650 0 4 _aOrf virus
650 0 4 _aRecombinant Fusion Proteins
650 0 4 _aSheep
650 0 4 _aThioredoxins
650 0 4 _aViral Proteins
_xpharmacology
650 0 4 _aeIF-2 Kinase
_xantagonists & inhibitors
700 1 _aMcInnes, C J
700 1 _aThomson, J
700 1 _aWood, A
700 1 _aBunyan, K
700 1 _aMercer, A
773 0 _tImmunology
_gvol. 93
_gno. 3
_gp. 335-40
856 4 0 _uhttps://doi.org/10.1046/j.1365-2567.1998.00438.x
_zAvailable from publisher's website
999 _c9606505
_d9606505